Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avian Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Not applicableStudy completedNCT00337896
What this trial is testing

T and B Cell Response to Avian Flu Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00771615
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Who this might be right for
Influenza
GlaxoSmithKline 469
Testing effectiveness (Phase 2)Study completedNCT04669691
What this trial is testing

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

Who this might be right for
Influenza, Human
Seqirus 420
Testing effectiveness (Phase 2)Study completedNCT00402649
What this trial is testing

Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT03369808
What this trial is testing

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

Who this might be right for
H7N9 Influenza
Shanghai Institute Of Biological Products 360
Early research (Phase 1)Study completedNCT01317758
What this trial is testing

H5N1 Mix and Match With AS03

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 245
Early research (Phase 1)Study completedNCT01675284
What this trial is testing

A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine

Who this might be right for
Bird FluAvian InfluenzaInfluenza A(H5N1)
Medigen Biotechnology Corporation 36
Post-approval studies (Phase 4)Active Not RecruitingNCT07275060
What this trial is testing

Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart

Who this might be right for
H5N1 InfluenzaH5N1 VirusAvian Influenza+1 more
Canadian Immunization Research Network 312
Testing effectiveness (Phase 2)Study completedNCT03738241
What this trial is testing

2017 A/H7N9 IIV Revaccination

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 304
Testing effectiveness (Phase 2)Study completedNCT05422326
What this trial is testing

Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

Who this might be right for
Influenza, HumanInfluenza in BirdsRespiratory Tract Infections+5 more
Seqirus 260
Not applicableStudy completedNCT01074736
What this trial is testing

Host Genetic Susceptibility to Avian Influenza A/H5N1

Who this might be right for
Influenza A Virus/H5N1 Subtype
South East Asia Infectious Disease Clinical Research Network 500
Testing effectiveness (Phase 2)Study completedNCT01389466
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

Who this might be right for
Influenza
Green Cross Corporation 346
Testing effectiveness (Phase 2)Study completedNCT00695669
What this trial is testing

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Who this might be right for
Influenza
GlaxoSmithKline 312
Not applicableWithdrawnNCT00640302
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Early research (Phase 1)Study completedNCT03745274
What this trial is testing

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Who this might be right for
Influenza, Avian
AVIR Green Hills Biotechnology AG 36
Early research (Phase 1)Study completedNCT01928472
What this trial is testing

Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

Who this might be right for
H7N9 Influenza
Novartis Vaccines 402
Testing effectiveness (Phase 2)Study completedNCT00311649
What this trial is testing

Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 83
Testing effectiveness (Phase 2)Study completedNCT00680069
What this trial is testing

H5N1 (Clade 2) Vaccination of Adults and Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 517
Testing effectiveness (Phase 2)Study completedNCT02691130
What this trial is testing

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

Who this might be right for
InfluenzaHealthy
BiondVax Pharmaceuticals ltd. 224
Next Page